ADVERTISEMENT

Stocks To Watch: Alkem Labs, Biocon, Central Bank Of India, Wockhardt

SGX Nifty indicates a weak start to trade

Stocks To Watch: Alkem Labs, Biocon, Central Bank Of India, Wockhardt
  • Biocon to trade ex-bonus today
  • Wockhardt, Alkem Labs get U.S. FDA approval
  • RBI initiates Prompt Corrective Action against Central Bank of India
  • S&P upgrades outlook for Adani Ports to ‘Stable’
  • Jindal Saw reduces stake in foreign subsidiary

The Singapore traded SGX Nifty, an early indicator of Nifty’s performance in India, fell 0.43 percent to 9,600.

Here are the stocks to watch out for in today’s session:

  • Biocon: Ex-date for 2:1 bonus today. F&O lot size revised to 1,800 shares
  • Wockhardt: Gets tentative approval from the U.S. FDA for Bendamustine Hydrochloride injection, which is used in chemotherapy
  • Alkem Labs: Received U.S. FDA approval for Itraconazole capsules used to treat fungal infections

ADF Foods

  • Out of the 14.61 lakh shares held, promoter Ashok Thakkar sold 10 lakh shares or 4.7 percent stake at Rs 281.85 each
  • Naresh Kothari bought 4 lakh shares or 1.9 percent stake at Rs 285.3 each
  • Central Bank of India: RBI initiates prompt corrective action (PCA) against the bank on account of high net non-performing assets and negative return on assets
  • NTPC: Aims to produce 3 million tonnes of coal from its own mines in FY18
  • Adani Ports & SEZ: S&P revises outlook to ‘stable’ from ‘negative.’

Jindal Saw

  • Reduces stake in foreign subsidiary Jindal Tubular to 19 percent
  • Sells stake in Singapore-based unit
  • Closes its subsidiary in Spain

Sun Pharma Advanced Research Company

Announces top-line results of pivotal peak inspiratory flow (PIF) study and low dose pharmacokinetic (PK) study for Salmeterol - Fluticasone dry powder inhaler

The results confirms that our device is highly efficient and consistent in delivering more drug to the lungs and suitable for all classes of patients. We will consult the regulatory agencies in Europe to understand the potential path forward for SPARC DPI.
Anil Raghavan, CEO, SPARC

Other Corporate Announcements

  • Repco Home Finance: Allotted NCDs worth Rs 272 crore on private placement basis to International Finance Corporation
  • Credit Analysis and Research: Received approval from Registrar of Companies to change the name to 'CARE Ratings Ltd.' from Credit Analysis and Research Ltd.
  • M&M Financial Services: Issued and Allotted NCDs worth Rs 200 crore

Today’s Nifty Call

Stocks To Watch: Alkem Labs, Biocon, Central Bank Of India, Wockhardt

Brokerage Calls

  • AIA Engineering: Sharekhan initiates coverage with positive rating
  • Coal India: Cut to ‘Sell’ at Goldman with a price target of Rs 225
  • Info Edge India: Cut to ‘Hold’ at Sharekhan with a price target of Rs 1,075
  • Simplex Infrastructures: Cut to 'Underperform' at IDFC Securities

Source: Bloomberg

Bulk Deals

  • Ginni Filaments: Equity Intelligence India bought 3.68 lakh shares or 0.5 percent stake at Rs 49.2 each
  • Inditrade Capital: Shilpa Porinju Veliyath bought 1.42 lakh shares or 0.6 percent stake at Rs 45.74 each
  • MBL Infra: M&G Investment Management sold 4.11 lakh shares or 1 percent stake at Rs 31.49 each

Bombay Burmah Trading Corporation

  • Promoter Nusli Wadia bought additional 7.05 lakh shares or 1 percent stake at Rs 877 each
  • Archway investment company sold 11.8 lakh shares or 1.7 percent stake at Rs 877 each

Stocks In F&O Ban

  • Bank of India
  • HDIL
  • IndiaBulls RealEstate
  • Infibeam Incorporation
  • Kaveri Seeds
  • Oriental Bank of Commerce
  • Reliance Communications
  • Ujjivan Financial Services

Media Reports

  • Tata Power: Considering forensic audit of last year’s purchase of Welspun Renewables Energy. (Economic Times)
  • Vascon Engineering: SEBI seeks clarification on cancellation of Vascon deal with Lodha Arm. (Economic Times)
  • SBI: Banks’ exposure to telecom in not that huge, says Arundhati Bhattacharya. (Economic Times)
  • Mphasis: Raises $500 million from dollar bond sale. (Economic Times)
  • NTPC: Bidders raise concerns over NTPC’s Andaman storage-linked solar project.(BusinessLine)
  • Dr. Reddy’s Laboratories: Recalls over 3.25 lakh cartons of Zenatane capsules, acne drug, from U.S. (Business Line)
  • Shipping Corporation of India: NITI Aayog has proposed strategic sale of about 26 percent stake, which could fetch Rs 960 crore. (Business Line)
  • UCO Bank: Expects RBI relief on haircuts (Mint)
  • HDFC: Says redeemed some debentures before scheduled redemption. (Bloomberg)
  • Wipro: Wins I.T. applications managed services contract with Valmet. (Bloomberg)